ImmuPharma PLC
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom. Its peptide-based therapeutics focuses on autoimmunity and inflammation, and anti-infectives therapeutic areas. The company's lead product candidate includes P140, a peptide technology platform, which is in Phase III clinical trial that targets autoimmune diseases for systemic lup… Read more
ImmuPharma PLC (IMM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -2.979x
Based on the latest financial reports, ImmuPharma PLC (IMM) has a cash flow conversion efficiency ratio of -2.979x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-1.00 Million) by net assets (GBX336.70K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ImmuPharma PLC - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how ImmuPharma PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ImmuPharma PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ImmuPharma PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
QUANTUM RESOURCES
BE:QM3
|
N/A |
|
Tariq Glass Industries Ltd
KAR:TGL
|
N/A |
|
INTERTAINMENT
MU:ITN
|
N/A |
|
PT Merdeka Gold Resources Tbk
JK:EMAS
|
N/A |
|
Mitchell Resources Ltd
STU:C8MQ
|
-0.053x |
|
HAPV3Q
SA:HAPV3Q
|
N/A |
|
MELCO INTL DEVT
BE:MX7A
|
N/A |
|
BIALETTI INDUSTRIE
BE:32B
|
N/A |
Annual Cash Flow Conversion Efficiency for ImmuPharma PLC (2004–2024)
The table below shows the annual cash flow conversion efficiency of ImmuPharma PLC from 2004 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX-542.86K | GBX-1.77 Million | 3.259x | +352.29% |
| 2023-12-31 | GBX1.06 Million | GBX-1.36 Million | -1.292x | -38.87% |
| 2022-12-31 | GBX2.52 Million | GBX-2.35 Million | -0.930x | +15.06% |
| 2021-12-31 | GBX4.41 Million | GBX-4.83 Million | -1.095x | -217.56% |
| 2020-12-31 | GBX9.65 Million | GBX-3.33 Million | -0.345x | +56.96% |
| 2019-12-31 | GBX5.27 Million | GBX-4.22 Million | -0.801x | -29.36% |
| 2018-12-31 | GBX7.62 Million | GBX-4.72 Million | -0.619x | +49.93% |
| 2017-12-31 | GBX3.57 Million | GBX-4.42 Million | -1.237x | -5.76% |
| 2016-12-31 | GBX5.55 Million | GBX-6.49 Million | -1.170x | +52.34% |
| 2015-12-31 | GBX1.69 Million | GBX-4.15 Million | -2.454x | -462.18% |
| 2014-12-31 | GBX5.71 Million | GBX-2.49 Million | -0.437x | +39.73% |
| 2013-12-31 | GBX5.40 Million | GBX-3.91 Million | -0.724x | -87.19% |
| 2012-12-31 | GBX8.42 Million | GBX-3.26 Million | -0.387x | -43.72% |
| 2011-12-31 | GBX12.51 Million | GBX-3.37 Million | -0.269x | +37.19% |
| 2010-12-31 | GBX15.97 Million | GBX-6.84 Million | -0.429x | -164.78% |
| 2009-12-31 | GBX18.08 Million | GBX11.96 Million | 0.662x | +389.02% |
| 2008-12-31 | GBX11.24 Million | GBX-2.57 Million | -0.229x | +80.78% |
| 2007-12-31 | GBX3.05 Million | GBX-3.63 Million | -1.191x | -239.23% |
| 2006-03-31 | GBX2.50 Million | GBX-879.00K | -0.351x | -1391.04% |
| 2005-03-31 | GBX993.00K | GBX27.00K | 0.027x | +2559.21% |
| 2004-03-31 | GBX978.00K | GBX1.00K | 0.001x | -- |